Result Number | Material Type | Add to My Shelf Action | Record Details and Options |
---|---|---|---|
1 |
Material Type: Artigo
|
![]() |
Response, Survival, and Long-Term Toxicity After Therapy With the Radiolabeled Somatostatin Analogue [90Y-DOTA]-TOC in Metastasized Neuroendocrine CancersIMHOF, Anna ; BRUNNER, Philippe ; MARINCEK, Nicolas ; BRIEL, Matthias ; SCHINDLER, Christian ; RASCH, Helmut ; MÄCKE, Helmut R ; ROCHLITZ, Christoph ; MÜLLER-BRAND, Jan ; WALTER, Martin AJournal of clinical oncology, 2011-06, Vol.29 (17), p.2416-2423 [Periódico revisado por pares]Alexandria, VA: American Society of Clinical OncologyTexto completo disponível |
2 |
Material Type: Artigo
|
![]() |
Cohort Study of Somatostatin-Based Radiopeptide Therapy With [90Y-DOTA]-TOC Versus [90Y-DOTA]-TOC Plus [177Lu-DOTA]-TOC in Neuroendocrine CancersVILLARD, Linda ; ROMER, Anna ; BRIEL, Matthias ; WALTER, Martin A ; MARINCEK, Nicolas ; BRUNNER, Philippe ; KOLLER, Michael T ; SCHINDLER, Christian ; NG, Quinn KT ; MÄCKE, Helmut R ; MÜLLER-BRAND, Jan ; ROCHLITZ, ChristophJournal of clinical oncology, 2012-04, Vol.30 (10), p.1100-1106 [Periódico revisado por pares]Alexandria, VA: American Society of Clinical OncologyTexto completo disponível |
3 |
Material Type: Artigo
|
![]() |
Toxic Encephalopathy Induced by CapecitabineNiemann, B. ; Rochlitz, C. ; Herrmann, R. ; Pless, M.Oncology, 2004-01, Vol.66 (4), p.331-335 [Periódico revisado por pares]Basel, Switzerland: KargerTexto completo disponível |
4 |
Material Type: Artigo
|
![]() |
[90Yttrium-DOTA]-TOC Response Is Associated With Survival Benefit in Iodine-Refractory Thyroid Cancer : Long-term Results of a Phase 2 Clinical TrialITEN, Fabienne ; MULLER, Beat ; SCHINDLER, Christian ; RASCH, Helmut ; ROCHLITZ, Christoph ; OERTLI, Daniel ; MAECKE, Helmut R ; MULLER-BRAND, Jan ; WALTER, Martin ACancer, 2009-05, Vol.115 (10), p.2052-2062 [Periódico revisado por pares]Hoboken, NJ: Wiley-BlackwellTexto completo disponível |
5 |
Material Type: Artigo
|
![]() |
Current Concepts of Treatment Strategies in Advanced or Recurrent Ovarian CancerSalzberg, Marc ; Thürlimann, Beat ; Bonnefois, Hervé ; Fink, Daniel ; Rochlitz, Christoph ; von Moos, Roger ; Senn, HansjörgOncology, 2005-01, Vol.68 (4-6), p.293-298 [Periódico revisado por pares]Basel, Switzerland: KargerTexto completo disponível |
6 |
Material Type: Artigo
|
![]() |
Prognostic and Predictive Relevance of DNAM-1, SOCS6 and CADH-7 Genes on Chromosome 18q in Colorectal CancerStorojeva, Iana ; Boulay, Jean-Louis ; Ballabeni, Pierluigi ; Buess, Martin ; Terracciano, Luigi ; Laffer, Urban ; Mild, Gabriele ; Herrmann, Richard ; Rochlitz, ChristophOncology, 2005-01, Vol.68 (2-3), p.246-255 [Periódico revisado por pares]Basel, Switzerland: KargerTexto completo disponível |
7 |
Material Type: Artigo
|
![]() |
Phase I clinical trial with IL-2-transfected xenogeneic cells administered in subcutaneous metastatic tumours: clinical and immunological findingsTARTOUR, E ; MEHTALI, M ; HERRMANN, R ; POUILLART, P ; FRIDMAN, W. H ; DORVAL, T ; SASTRE-GARAU, X ; JOYEUX, I ; MATHIOT, C ; PLEAU, J. M ; SQUIBAN, P ; ROCHLITZ, C ; COURTNEY, M ; JANTSCHEFF, PBritish Journal of Cancer, 2000-12, Vol.83 (11), p.1454-1461 [Periódico revisado por pares]Basingstoke: Nature Publishing GroupTexto completo disponível |